Ergoteles LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2022$741,000
-95.2%
30,739
-94.6%
0.03%
-94.4%
Q2 2022$15,498,000
+16564.5%
566,024
+20595.6%
0.46%
+23100.0%
Q2 2021$93,000
-99.7%
2,735
-99.7%
0.00%
-99.8%
Q1 2021$27,580,000
+5856.8%
848,617
+6503.0%
0.86%
+5620.0%
Q4 2020$463,000
+26.8%
12,852
+37.8%
0.02%
-68.8%
Q3 2020$365,0009,3240.05%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders